Shahroo Etemad-Moghadam DDS, MSc

*

CURRICULUM VITAE

Date of Revision: 10/31/2020

Contact Details:

**** ******** ***** **

Thousand Oaks, CA 91362

Phone: 805-***-****

Email: adhp91@r.postjobfree.com

Residency status: USA green card holder

Education:

MSc Tehran University of Medical Sciences (Oral and Maxillofacial Pathology), 2001-2004 DDS Tehran Azad University of Medical Sciences, 1989-1996 Career/Academic Appointments:

2015-present Associate Professor, Dental Research Center Tehran University of Medical Sciences 2007-2015 Assistant Professor, Dental Research Center Tehran University of Medical Sciences 2004-2007 Assistant Professor, Faculty of Dentistry, Qazvin University of Medical Sciences Administrative Positions:

2015-present Associate Vice Chancellor for International Affairs, Dentistry Research Institute, Tehran University of Medical Sciences

2015-2018 Vice Chancellor for Research, Dentistry Research Institute, Tehran University of Medical Sciences

2006-2007 Advisory Professor, Faculty of Dentistry, Qazvin University of Medical Sciences Other work experience:

1998-1998 Observer at the Armed Forces Institute of Pathology (AFIP), Washington D.C. Board Certification:

National Board of Oral and Maxillofacial Pathology, Iran, 2004 Professional Honors & Recognition (list from most recent to earliest): International/National/Regional

2009: First place prize for best article in the 10th Annual Hedayat Symposium 2008: First place prize for Supervising an Undergraduate Thesis in the 9th Annual Hedayat Symposium

2008: First place prize for best article in the 9th Annual Hedayat Symposium 2007: First place prize for best article in the 8th Annual Hedayat Symposium 2006: First place prize for Supervising an Undergraduate Thesis in the 7th Annual Hedayat Symposium.

2004: First place prize for Master thesis in the 5th Annual Hedayat Symposium 2004: First place position in the National Board exam of Oral and Maxillofacial Pathology University

2005: Professor of the year, Qazvin University of Medical Sciences Shahroo Etemad-Moghadam DDS, MSc

2

Grant/Clinical Trials History: (list from most recent to earliest; total % effort on active grants and clinical trials must not exceed % effort toward research listed on CV Supplement) Current Grants

Agency: Tehran University of Medical Sciences (TUMS) I.D.# 99-2-134-49162

Title: “Comparison of hypoxia-related gene expression in oral squamous carcinoma and normal mucosa”

P.I.: Shahroo Etemad-Moghadam, DDS, MS

Percent effort: 25%

Direct costs per year: 259,200,000 IRR

Total costs for project period: 259,200,000 IRR $926 [exchange rate: $1 280,000 IRR; $PPP

(purchasing power parity) not available]

Project period: 1 year (pending contract finalization) Past Grants

Agency: Tehran University of Medical Sciences (TUMS) I.D.# 97-04-70-411**

Title: “ADAM10, E-Cadherin and CD44 expression in oral squamous cell carcinoma” P.I.: Shahroo Etemad-Moghadam, DDS, MS

Percent effort: 33%

Total costs for project period: 174,993,000 IRR $1250 (exchange rate: $1 280,000 IRR; $PPP not available)

Project period: 6 months, 11/02/2019 – 09/13/2019

Agency: Tehran University of Medical Sciences (TUMS) I.D.# 94-04-70-314**

Title: “Comparative study of the expression of Kindlin1 and Kindlin2 genes and proteins in oral squamous carcinoma and normal mucosa”

P.I.: Shahroo Etemad-Moghadam, DDS, MS

Percent effort: 25%

Total costs for project period: 206,750,000 IRR ($PPP*: 11,796.811 – >13,061.29) Project period: 24 months, 08/02/2016 – 08/03/2018 Agency: Tehran University of Medical Sciences (TUMS) I.D.# 93-02-70-252**

Title: “Comparison of pattern of invasion between squamous cell carcinomas of the lower lip and oral cavity”

P.I.: Shahroo Etemad-Moghadam, DDS, MS

Percent effort: 33%

Total costs for project period: 77,550,000 IRR ($PPP: 10,701.562 – 11,796.811) Project period: 20 months, 01/05/2015 – 09/05/2016 Agency: Tehran University of Medical Sciences (TUMS) I.D.# 93-02-70-240**

* https://data.worldbank.org/indicator/PA.NUS.PPP?locations=IR&most_recent_year_desc=false Shahroo Etemad-Moghadam DDS, MSc

3

Title: “Association of stromal factors with histologic risk assessment model in oral squamous cell carcinoma”

P.I.: Shahroo Etemad-Moghadam, DDS, MS

Percent effort: 20%

Total costs for project period: 148,100,000 IRR ($PPP: 9,758.554 – 11,796.811) Project period: 19 months, 10/11/2014 – 05/11/2016 Agency: Tehran University of Medical Sciences (TUMS) I.D.# 91-01-70-170**

Title: “ADAM10, Angiogenesis and EGFR in Oral SCC” P.I.: Shahroo Etemad-Moghadam, DDS, MS

Percent effort: 33%

Total costs for project period: 59,090,000 IRR ($PPP: 6,093.563 – 9,758.554) Project period: 21 months, 06/09/2012 – 03/09/2014 Agency: Tehran University of Medical Sciences (TUMS) I.D.# 91-01-70-169**

Title: “Comparative expression of proliferation markers Ki67 and Mcm2 and geminin in squamous cell carcinoma of the lip, oral cavity and skin”

P.I.: Shahroo Etemad-Moghadam, DDS, MS

Percent effort: 33%

Total costs for project period: 93,440,000 IRR ($PPP: 6,093.563 – 9,758.554) Project period: 21 months, 09/19/2012 – 06/19/2014 Agency: Tehran University of Medical Sciences (TUMS) I.D.# 90-01-70-134**

Title: “Immunohistochemical comparison of mini-chromosome maintenance protein-2, CD44, CD24, CD105, E-cadherin and Matrix metalloproteinase-9 in metastatic and non-metastatic oral SCC” P.I.: Shahroo Etemad-Moghadam, DDS, MS

Percent effort: 33%

Total costs for project period: 99,408,000 IRR ($PPP: 4,758.87 – 8,503.847) Project period: 23 months, 08/02/2011 – 07/02/2013 Agency: Tehran University of Medical Sciences (TUMS) I.D.# 89-03-70-107**

Title: “Podoplanin and TGF-beta expression in odontogenic tumors” P.I.: Shahroo Etemad-Moghadam, DDS, MS

Percent effort: 25%

Total costs for project period: 42,908,000 IRR ($PPP: 3,926.104 – 6,093.563) Project period: 23 months, 12/11/2010 – 11/11/2012 Agency: Tehran University of Medical Sciences (TUMS) I.D.# 89-02-70-108**

Title: “Comparison of Podoplanin, N-cadherin and E-cadherin between Oral Squamous Cell Carcinoma and Normal/Hyperpalstic Epithelium”

P.I.: Shahroo Etemad-Moghadam, DDS, MS

Percent effort: 33%

Total costs for project period: 70,408,000 IRR ($PPP: 3,926.104 – 6,093.563) Project period: 23 months, 09/26/2010 – 08/26/2012 Shahroo Etemad-Moghadam DDS, MSc

4

Agency: Tehran University of Medical Sciences (TUMS) I.D.# 88-02-70-8828

Title: “Comparison of angiogenesis in odontogenic keratocyst and radicular cyst” P.I.: Shahroo Etemad-Moghadam, DDS, MS

Percent effort: 20%

Total costs for project period: 20,728,000 IRR ($PPP: 3,427.479 – 4758.87) Project period: 16 months, 12/22/2009 – 04/22/2011 Agency: Tehran University of Medical Sciences (TUMS) I.D.# 87-04-70-8045

Title: “Evaluation of DNA replication licensing factors in diffuse large cell B lymphomas of the head and neck`”

P.I.: Shahroo Etemad-Moghadam, DDS, MS

Percent effort: 14%

Total costs for project period: 101,594,000 IRR ($PPP: 3,926.104) Project period: 22 months, 1/20/2009 – 11/20/2010

Past Clinical Trials

Agency: Qazvin University of Medical Sciences

I.D.# ClinicalTrials.gov Identifier: NCT00746772, Other Study ID Number: ACTG 023 Title: “Efficacy of Purslane in Treatment of Oral Lichen Planus” P.I.: Aida(touba) Karagah, DDS

Role on Project: Study Director

Percent effort: 17%

Total costs for project period: 45,000,000 IRR ($PPP: 3,926.104) Project period: 9/2/2008 – 9/2/2009

Invited Speaking Engagements, Presentations, Symposia & Workshops Not Affiliated With Home Institution: (list from most recent to earliest)

International/National

2020: 5th Congress of Iranian Oral and Maxillofacial Pathologists’ Association, Iran (online),

“Comparison of Routine and Microwave-assisted Decalcification of Bone with or without Teeth: A Histologic Study” (poster presentation)

2016: 8th International Congress of Medical Laboratory and Clinics and the 1st National Congress of Medical Basic Sciences and Knowledge-based Production, Tehran, Iran: “Effect of Naltrexone and L-NAME on bone densitometry in bile duct ligated rats” (poster presentation). 2016: 8th International Congress of Medical Laboratory and Clinics and the 1st National Congress of Medical Basic Sciences and Knowledge-based Production, Tehran, Iran: “Effect of Naltrexone and L-NAME on bone histomorphometry and calcium in bile duct ligated rats. 2008: 10th Annual Congress of Iranian Pathology and the 4th Congress of Iranian Cancer Association, Tehran, Iran, “Evaluation of Angiogenesis in Salivary Gland Mucoepidermoid Carcinoma and its Relation to Histologic Grade”

2008: 2nd International Congress of Medical Ethics, Tehran, Iran, “Ethics in Dentistry” Shahroo Etemad-Moghadam DDS, MSc

5

2003: 16th Congress of Physiology and Pharmacology, Tehran, Iran, “Nitric Oxide Overproduction in Cholestatic Rats Is Responsible for Increased Orthodontic Tooth Movement” (poster presentation)

Professional Service

Peer Review Groups/Grant Study Sections: (list from most recent to earliest) 2010-present Member of the Research Council, Dental Research Center Tehran University of Medical Sciences

2017-2018 Member of the Ethics Committee, School of Dentistry, Tehran University of Medical Sciences

2005-2007 Member of the Research Council, Faculty of Dentistry, Qazvin University of Medical Sciences

Journal Service:

Editor/Associate Editor

2020-present Associate Editor, “BMC Cancer”

2019-present Associate Editor, “Frontiers in Dentistry” 2014-2019 Editorial Board Member, “Journal of Dentistry Tehran University of Medical Sciences” 2006-2007 English Editor of “Majallah-I-Dandanpizishki, The Journal of Islamic Dental Association of Iran”

2005 Literature Editor of “Journal of Dentistry Tehran University of Medical Sciences” Reviewer

2007-present Reviewer for Micron; Journal of Oral Pathology and Medicine; Pathology, Research and Practice; Pathobiology, BMC Cancer, Journal of Medical Case Reports; Journal of Clinical and Diagnostic Research; Brazilian Dental Journal; Journal of Biosciences and Medicine; International Journal of Oral and Craniofacial Science, and several other international and national journals Public Service:

1999 Oral and Dental Health Care Examination of Children with Special Needs - Irshad School of Children with Special Needs, Tehran, Iran Bibliography: (list from earliest to most recent and number consecutively) Peer-Reviewed Original Research

1. Etemad-Moghadam S (corresponding author), Baghaee F, Tirgary F, Motahhary P, Khalili M, Eshghyar N, Alaedini M, Eslami M. Expression of p21WAF in Salivary Gland Mucoepidermoid Carcinoma and its Relation to Histological Grade. Int J Surg Pathol. 2007;15(1): 6-13. 2. Alaeddini M, Etemad-Moghadam S, Baghaii F. Comparative Expression of Calretinin in Selected Odontogenic Tumors: a possible Relationship to Histogenesis. Histopathology. 2008 Feb;52(3):299-304.

Shahroo Etemad-Moghadam DDS, MSc

6

3. Alaeddini M, Khalili M, Tirgary F, Etemad-Moghadam S (corresponding author). Argyrophilic Proteins of Nuclear Organizer Regions (AgNORs) in Salivary Gland Mucoepidermoiod Carcinoma and its Relation to Histological Grade. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Jun;105(6):758-62.

4. Etemad-Moghadam S, Khalili M, Tirgary F, Alaeddini M. Evaluation of Myofibroblasts in Oral Epithelial Dysplasia and Squamous Cell Carcinoma. J Oral Pathol Med. 2009 Sep;38(8):639-43. 5. Alaeddini M, Salah S, Dehghan F, Eshghyar N, Etemad-Moghadam S (corresponding author). Comparison of Angiogenesis in Keratocystic Odontogenic Tumors, Dentigerous Cysts and Ameloblastomas. Oral Dis. 2009 Sep;15(6):422-7.

6. Agha-Hosseini F, Borhan-Mojabi K, Monsef-Esfahani HR, Mirzaii-Dizgah I, Etemad- Moghadam S, Karagah A. Efficacy of Purslane in the treatment of oral lichen planus. Phytother Res. 2010 Feb;24(2):240-4.

7. Alaeddini M, Salehizadeh S, Baghaii F, Etemad-Moghadam S (corresponding author). A Retrospective Analysis of Peripheral Odontogenic Fibroma in an Iranian Population. J Oral Maxillofac Surg. 2010 Sep;68(9):2099-103.

8. Etemad-Moghadam S, Tirgary F, Keshavarz S, Alaeddini M. Head and neck non-Hodgkin's lymphoma: a 20-year demographic study of 381 cases. Int J Oral Maxillofac Surg. 2010 Sep;39(9):869-72.

9. Javaheri M, Maleki Kambakhsh S, Etemad-Moghadam S. Efficacy of two caries detector dyes in the diagnosis of dental caries. J Dent (Tehran). 2010 Spring;7(2):71-6. 10. Alaeddini M, Azizi E, Fouladdel S, Etemad-Moghadam S (corresponding author). Expression of Fascin Protein and mRNA in the KB Carcinoma Cell Line Following Treatment with Doxorubicin. J Cancer Res Ther. J Cancer Res Ther. 2011 Oct-Dec;7(4):427-32. 11. Alaeddini M, Mostafaloo E, Mirmohammadkhani O, Eshghyar N, Etemad-Moghadam S

(corresponding author). Exploring the concept of “inflammatory angiogenesis” in keratocystic odontogenic tumor. Med Oral Patol Oral Cir Bucal. 2013 Mar 1;18(2):e241-5. 12. Etemad-Moghadam S, Azizi E, Fouladdel S, Alaeddini M. In vitro study on the effect of doxorubicin on proliferation markers MCM3 and Ki-67. J BUON. 2013 Oct-Dec;18(4):1062-8. 13. MirHashemi AH, Afshari M, Alaeddini M, Etemad-Moghadam S, Dehpour A, Sheikhzade S, Akhoundi MS. Effect of atorvastatin on orthodontic tooth movement in male Wistar rats. J Dent

(Tehran). 2013 Nov;10(6):532-9.

Shahroo Etemad-Moghadam DDS, MSc

7

14. Etemad-Moghadam S, Baghaee F, Dadafarid Z, Alaeddini M. A 44-year analysis of ghost cell odontogenic tumour subtypes in an Iranian population. J Craniomaxillofac Surg. 2014 Oct;42(7):1154-9.

15. Shirazi M, Alimoradi H, Kheirandish Y, Etemad-Moghadam S, Alaeddini M, Meysamie A, Fatahi Meybodi SA, Dehpour AR. Pantoprazole, a proton pump inhibitor, increases orthodontic tooth movement in rats. Iran J Basic Med Sci. 2014;17(6):448-53. 16. Sahebjamee M, Mansourian A, Etemad-Moghadam S, Shamshiri AR, Derakhshan S. Conventional versus Papanicolaou-stained cytobrush biopsy in the diagnosis of oral squamous cell carcinoma. Oral Health Dent Manag. 2014 Sep;13(3):619-22. 17. Etemad-Moghadam S, Chookhachizadeh S, Baghaii F, Alaeddini M. Odontogenic myxoma: A study based on biopsy material over a 40-year period. J Contemp Dent Pract. 2014 Mar 1;15(2):137-41.

18. Alaeddini M, Barghammadi R, Eshghyar N, Etemad-Moghadam S (corresponding author). An analysis of biopsy-proven tongue lesions among 8105 dental outpatients from Tehran. J Contemp Dent Pract. 2014 Jan 1;15(1):1-7.

19. Paknejad M, Baghaban Eslaminejad M, Ghaedi B, Rokn A, Khorsand A, Etemad-Moghadam S, Alaeddini M, Dehghan M, Moslemi N, Nowzari H. Isolation and assessment of mesenchymal stem cells derived from bone marrow: histologic and histomorphometric study in a canine periodontal defect. J Oral Implantol. 2015 Jun;41(3):284-91.

20. Alaeddini M, Etemad-Moghadam S (corresponding author). Immunohistochemical profile of oral mucosal and head and neck cutaneous melanoma. J Oral Pathol Med. 2015 Mar;44(3):234-8. 21. Etemad-Moghadam S, Mojgan Alaeddini. Invasion Phenotypes of Oral Squamous Cell Carcinoma. Appl Immunohistochem Mol Morphol. 2015 Sep;23(8):e12-6. 22. Etemad-Moghadam S, Mojgan Alaeddini. p53 and p27kip1 status in Iranian patients with oral squamous cell carcinoma. Iran Red Crescent Med J. 2015 Oct 19;17(10):e19359. 23. Alaeddini M, Abachi H, Abbasi S, Shamshiri AR, Etemad-Moghadam S (corresponding author). Association of Stromal Factors with the Histologic Risk Assessment Model in Oral Squamous Cell Carcinoma. Appl Immunohistochem Mol Morphol. 2015 Oct 27. [Epub ahead of print] PMID: 26509910

Shahroo Etemad-Moghadam DDS, MSc

8

24. Rokn AR, Shakeri AS, Etemad-Moghadam S, Alaeddini M, Shamshiri AR, Manasheof R, Barikani H. Regenerative Effects of Three Types of Allografts on Rabbit Calvarium: An Animal Study. J Dent (Tehran). 2015 Nov;12(11):823-34.

25. Alaeddini M, Etemad-Moghadam S (corresponding author). Lymphangiogenesis and angiogenesis in oral cavity and lower lip squamous cell carcinoma. Braz J Otorhinolaryngol. 2016 Jul-Aug;82(4):385-90.

26. Alaeddini M, Eshghyar N, Etemad-Moghadam S (corresponding author). Expression of podoplanin and TGF-beta in glandular odontogenic cyst and its comparison with developmental and inflammatory odontogenic cystic lesions. J Oral Pathol Med. 2017 Jan;46(1):76-80. 27. Doustimotlagh AH, Dehpour AR, Etemad-Moghadam S, Alaeddini M, Kheirandish Y, Golestani A. Nitrergic and opioidergic systems affect radiographic density and histomorphometric indices in bile-duct-ligated cirrhotic rats. Histol Histopathol. 2016 Oct 26:11836. 28. Alaeddini M, Etemad-Moghadam S (corresponding author). Correlation between invasion mode and the histologic risk assessment model in oral squamous cell carcinoma. Oral Maxillofac Surg. 2016 Dec;20(4):353-358.

29. Mirhashemi AH, Akhoundi MS, Ghazanfari R, Etemad-Moghadam S, Alaeddini M, Khorshidian A, Dehpour AR, Momeni N. Assessment of the Role of NO-cGMP Pathway in Orthodontic Tooth Movement Using PDE5 Inhibitors: An Animal Study. J Dent (Tehran). 2016 Nov;13(6):388-393. 30. Etemad-Moghadam S, Alaeddini M. A comparative study of syndecan-1 expression in different odontogenic tumors. J Oral Biol Craniofac Res. 2017 Jan-Apr;7(1):23-26. 31. Shirazi M, Vaziri H, Salari B, Motahhari P, Etemad-Moghadam S, Dehpour AR. The effect of caffeine on orthodontic tooth movement in rats. Iran J Basic Med Sci. 2017 Mar;20(3):260-264. 32. Alaeddini M, Etemad-Moghadam S (corresponding author). Comparison of the histologic risk assessment model between lower lip and oral squamous cell carcinoma. J Stomatol Oral Maxillofac Surg. 2017 Nov 8. pii: S2468-7855(17)30200-8. doi: 10.1016/j.jormas.2017.11.005. 33. Etemad-Moghadam S, Alaeddini M. Pattern of invasion in squamous cell carcinomas of the lower lip and oral cavity. J Oral Biol Craniofac Res. 2017 Sep-Dec;7(3):167-170. 34. Alaeddini M, Etemad-Moghadam S (corresponding author). Are Ski and SnoN Involved in the Tumorigenesis of Oral Squamous Cell Carcinoma Through Smad4? Appl Immunohistochem Mol Morphol. 2019 Sep;27(8):626-630. doi: 10.1097/PAI.0000000000000667. Shahroo Etemad-Moghadam DDS, MSc

9

35. Doustimotlagh AH, Dehpour AR, Etemad-Moghadam S, Alaeddini M, Ostadhadi S, Golestani A. A study on OPG/RANK/RANKL axis in osteoporotic bile duct-ligated rats and the involvement of nitrergic and opioidergic systems. Res Pharm Sci. 2018 Jun;13(3):239-249. doi: 10.4103/1735- 5362.228954.

36. Etemad-Moghadam S, Alaeddini M. Is podoplanin expression associated with transforming growth factor-β signaling in odontogenic cysts and tumors? J Oral Pathol Med. 2018 May;47(5):519-525. doi: 10.1111/jop.12710.

37. Alaeddini M, Yazdani F, Etemad-Moghadam S (corresponding author). Stromal and epithelial syndecan-1 expression in benign and malignant salivary gland tumors: which is more reflective of behavior? Braz J Otorhinolaryngol. 2019 Sep 4. pii: S1808-8694(19)30091-6. doi: 10.1016/j.bjorl.2019.07.006.

38. Hemmati S, Rahimi N, Dabiri S, Alaeddini M, Etemad-Moghadam S, Dehpour AR. Inhibition of ovalbumin-induced allergic rhinitis by sumatriptan through the nitric oxide pathway in mice. Life Sci. 2019 Nov 1;236:116901. doi: 10.1016/j.lfs.2019.116901. 39. Pourshahidi S, Ghasemzadeh Hoseini E, Ebrahimi H, Alaeddini M, Etemad-Moghadam S. A Model for Induction of Dysplasia in Hamster Mucosal Pouch. Front Dent. 2019 Sep- Oct;16(5):402-406. doi: 10.18502/fid.v16i5.2291.

40. Etemad-Moghadam S, Alaeddini M. Upregulation of ADAM10 in oral squamous cell carcinoma and its correlation with EGFR, neoangiogenesis and clinicopathologic factors. J Craniomaxillofac Surg. 2019 Jul 19. pii: S1010-5182(19)30114-3. doi: 10.1016/j.jcms.2019.07.008. 41. Pourhajibagher M, Partoazar A, Alaeddini M, Etemad-Moghadam S, Bahador A. Photodisinfection effects of silver sulfadiazine nanoliposomes doped-curcumin on Acinetobacter baumannii: a mouse model. Nanomedicine (Lond). 2020 Feb;15(5):437-452. doi: 10.2217/nnm- 2019-0315.

42. Saffari PM, Alijanpour S, Takzaree N, Sahebgharani M, Etemad-Moghadam S, Noorbakhsh F, Partoazar A. Metformin loaded phosphatidylserine nanoliposomes improve memory deficit and reduce neuroinflammation in streptozotocin-induced Alzheimer's disease model. Life Sci. 2020 Aug 15;255:117861. doi: 10.1016/j.lfs.2020.117861. 43. Eskandarynasab M, Doustimotlagh AH, Takzaree N, Etemad-Moghadam S, Alaeddini M, Dehpour AR, Goudarzi R, Partoazar A. Phosphatidylserine nanoliposomes inhibit glucocorticoid- induced osteoporosis: A potential combination therapy with alendronate. Life Sci. 2020 Sep 15;257:118033. doi: 10.1016/j.lfs.2020.118033.

Shahroo Etemad-Moghadam DDS, MSc

10

44. Eskandarynasab M, Etemad-Moghadam S, Alaeddini M, Doustimotlagh AH, Nazeri A, Dehpour AR, Goudarzi R, Partoazar A. Novel osteoprotective nanocochleate formulation: A dual combination therapy-codelivery system against glucocorticoid induced osteoporosis. Nanomedicine. 2020 Oct;29:102273. doi: 10.1016/j.nano.2020.102273. 45. Alaeddini M, Etemad-Moghadam S (corresponding author). Cell kinetic markers in cutaneous squamous and basal cell carcinoma of the head and neck. Braz J Otorhinolaryngol. 2020 Sep 12:S1808-8694(20)30140-3. doi: 10.1016/j.bjorl.2020.07.010. Peer-Reviewed Original Research in Local Journals

46. Shirazi M, Etemad-Moghadam S. Skeletodental Changes During The Pubertal Growth Spurt In Class II Div I Females: A Longitudinal Study. Acta Medica Iranica. 1996;34(3, 4): 89-94. 47. Alaeddini M, Etemad-Moghadam S (corresponding author). A report on the significance of ethics in dental research in Iran. J Dent Med. 2014 27(2):144-51. 48. Khorshidian A, Momeni N, Alaeddini M, Etemad-Moghadam S. Ethics education in Dentistry. Ethics in Science and Technology. 2008 3(3,4):85-91. 49. Etemad-Moghadam S, Alaeddini M, Mozaffari B. Angiogenesis in salivary gland mucoepidermoid carcinoma and its relation to histologic grading. JIDA. 2010;22(1):35-41. 50. Alaeddini M, Mousavi D, Eshghyar N, Etemad-Moghadam S (corresponding author). Evaluation of eosinophilic infiltration in oral squamous cell carcinoma and its correlation with cervical lymph node metastasis and histological grading. JIDA. 2010;22(2):93-99. 51. Alaeddini M, Etemad-Moghadam S (corresponding author). Fascin expression in keratocystic odontogenic tumor and dentigerous cyst. JIDA. 2012;24(4):318-323. 52. Etemad-Moghadam S, Gholamhosseini A, Khorshidian A, Alaeddini M. Comparison of mast cell density in histologic differentiation of oral squamous cell carcinoma based on three different valid grading systems. J Isfahan Dent Sch. 2013;9(6):509-17. Chapters, Books, and Reviews

53. Etemad-Moghadam S. Future perspectives of botulinum toxin application in dentistry. In: Botulinum toxin treatment in Surgery, Dentistry, and Veterinary Medicine, Jabbari B editor. Springer Nature Switzerland AG 2020, pp. 359-391.

Shahroo Etemad-Moghadam DDS, MSc

11

54. Wong C, Etemad-Moghadam S, Jabbari B. Botulinum Toxins for Treatment of Pain in Orthopedic Disorders. In: Botulinum toxin treatment in Surgery, Dentistry, and Veterinary Medicine, Jabbari B editor. Springer Nature Switzerland AG 2020, pp 195-217. 55. Botulinum toxin Treatment in Surgery, Dentistry and Veterinary Medicine. Jabbari B (Ed), Etemad- Moghadam S (Asst. Ed), Springer Nature Switzerland AG 2020. Practice Guidelines, Standards and Consensus Statements 56. ISO 7405 standard: study of biocompatibility of instruments used in dentistry (Persian) Case Reports, Technical Notes, Letters

57. Alaeddini M, Etemad-Moghadam (corresponding author). Dental Research challenges in the time of COVID-19 and future perspectives. CRANIO: The Journal of Craniomandibular & Sleep Practice. To be published in the upcoming January ’21 issue

Contact this candidate